JP2009240315A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009240315A5 JP2009240315A5 JP2009138688A JP2009138688A JP2009240315A5 JP 2009240315 A5 JP2009240315 A5 JP 2009240315A5 JP 2009138688 A JP2009138688 A JP 2009138688A JP 2009138688 A JP2009138688 A JP 2009138688A JP 2009240315 A5 JP2009240315 A5 JP 2009240315A5
- Authority
- JP
- Japan
- Prior art keywords
- hiv
- sequence
- peptide
- deposited
- derived
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims 6
- 101800001690 Transmembrane protein gp41 Proteins 0.000 claims 3
- 241000700605 Viruses Species 0.000 claims 3
- 150000001413 amino acids Chemical class 0.000 claims 3
- 238000002405 diagnostic procedure Methods 0.000 claims 3
- 208000015181 infectious disease Diseases 0.000 claims 3
- 241001430294 unidentified retrovirus Species 0.000 claims 3
- 238000000338 in vitro Methods 0.000 claims 2
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 claims 2
- 108091035707 Consensus sequence Proteins 0.000 claims 1
- 125000000539 amino acid group Chemical group 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 239000012472 biological sample Substances 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000001900 immune effect Effects 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9412554A FR2726006B1 (fr) | 1994-10-20 | 1994-10-20 | Sequences nucleotidiques codant des antigenes d'un retrovirus du type vih-1 groupe o |
| FR9502526A FR2731225B1 (fr) | 1995-03-03 | 1995-03-03 | Peptides de glycoproteine transmembranaire d'enveloppe et de proteine de capside du retrovirus humain du type hiv-1 et peptides presentant avec eux une parente immunologique |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008121431A Division JP4589420B2 (ja) | 1994-10-20 | 2008-05-07 | Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009240315A JP2009240315A (ja) | 2009-10-22 |
| JP2009240315A5 true JP2009240315A5 (enExample) | 2010-02-25 |
Family
ID=26231483
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51369296A Expired - Lifetime JP4278174B2 (ja) | 1994-10-20 | 1995-10-20 | Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列 |
| JP2008121431A Expired - Lifetime JP4589420B2 (ja) | 1994-10-20 | 2008-05-07 | Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列 |
| JP2009138688A Withdrawn JP2009240315A (ja) | 1994-10-20 | 2009-06-09 | Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列 |
| JP2010048112A Withdrawn JP2010172335A (ja) | 1994-10-20 | 2010-03-04 | Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP51369296A Expired - Lifetime JP4278174B2 (ja) | 1994-10-20 | 1995-10-20 | Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列 |
| JP2008121431A Expired - Lifetime JP4589420B2 (ja) | 1994-10-20 | 2008-05-07 | Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010048112A Withdrawn JP2010172335A (ja) | 1994-10-20 | 2010-03-04 | Ｈｉｖ−１のｏグループ（またはサブグループ）レトロウイルス性抗原のヌクレオチド配列 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US6399294B1 (enExample) |
| EP (2) | EP0787191B2 (enExample) |
| JP (4) | JP4278174B2 (enExample) |
| CN (3) | CN102134609A (enExample) |
| AT (1) | ATE374253T1 (enExample) |
| AU (3) | AU715731B2 (enExample) |
| CA (2) | CA2202408C (enExample) |
| DE (1) | DE69535601T3 (enExample) |
| DK (1) | DK0787191T4 (enExample) |
| ES (1) | ES2293643T5 (enExample) |
| PT (1) | PT787191E (enExample) |
| WO (1) | WO1996012809A2 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT787191E (pt) * | 1994-10-20 | 2007-12-06 | Pasteur Institut | Sequências nucleotídicas de antigénios retroviraisde vih do tipo (ou sub-tipo) o |
| AU710468B2 (en) * | 1995-01-27 | 1999-09-23 | Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The | Methods for sensitive detection of reverse transcriptase |
| DE19505262C2 (de) * | 1995-02-16 | 1998-06-18 | Behring Diagnostics Gmbh | Retrovirus aus der HIV-Gruppe und dessen Verwendung |
| IL132166A0 (en) * | 1997-04-09 | 2001-03-19 | Pasteur Sanofi Diagnostics | Synthetic peptides which can be used in biological tests for the detection of infections due to group o hiv-1 viruses |
| FR2761993B1 (fr) * | 1997-04-09 | 1999-05-21 | Pasteur Sanofi Diagnostics | Peptides synthetiques utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 groupe 0 |
| FR2775287B1 (fr) * | 1998-02-24 | 2000-11-24 | Pasteur Sanofi Diagnostics | Peptides synthetiques consensus utilisables dans les essais biologiques pour la detection des infections dues aux virus vih 1 du groupe o |
| US6511801B1 (en) | 1997-07-18 | 2003-01-28 | Innogenetics, N.V. | HIV-1 group O antigens and uses thereof |
| US6846905B2 (en) | 1997-08-15 | 2005-01-25 | Abbott Laboratories | Antigen constructs useful in the detection and differentiation of antibodies to HIV |
| US5922533A (en) * | 1997-08-15 | 1999-07-13 | Abbott Laboratories | Rapid assay for simultaneous detection and differentiation of antibodies to HIV groups |
| AU2345399A (en) * | 1998-01-28 | 1999-08-16 | Universal Health-Watch, Inc. | Divergent hiv-1 peptides |
| CN1061092C (zh) * | 1998-02-27 | 2001-01-24 | 中国科学院上海生物化学研究所 | 白色念珠菌具有逆转录转座子结构的元件 |
| CA2288869A1 (en) * | 1998-03-04 | 1999-09-10 | Mary Ann Childs | Rapid confirmatory test for microbial infections |
| AU3670999A (en) * | 1998-04-30 | 1999-11-16 | Universal Health-Watch, Inc. | Immunoassay with mixed peptides |
| WO1999062945A2 (en) * | 1998-06-05 | 1999-12-09 | Peptide Solutions, Inc. | Peptide antigens for detection of hiv, hcv and other microbial infections |
| CA2676762C (en) * | 1998-11-30 | 2015-12-29 | Ortho-Clinical Diagnostics, Inc. | Peptides for the detection of hiv-1 group o |
| EP1187939B9 (en) * | 1999-07-09 | 2009-08-12 | Gen-Probe Incorporated | Detection of hiv-1 by nucleic acid amplification |
| US6818392B2 (en) | 2000-12-06 | 2004-11-16 | Abbott Laboratories | Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| EP2251442B9 (en) | 2003-12-19 | 2012-04-25 | Gen-Probe Incorporated | Compositions, methods and kits for detecting the nucleic acids of HIV-1 and HIV-2 |
| TW200613554A (en) * | 2004-06-17 | 2006-05-01 | Wyeth Corp | Plasmid having three complete transcriptional units and immunogenic compositions for inducing an immune response to HIV |
| AU2005335203A1 (en) | 2004-09-08 | 2007-02-15 | The United States Of America As Represented By The Secretary Of Health And Human Services, Nih | Compositions and methods for the detection of HIV-1/HIV-2 infection |
| EP1989326A4 (en) | 2006-01-17 | 2009-09-30 | Health Research Inc | BIO-HETERODUPLEX TRACKING TEST |
| US8405379B1 (en) | 2008-09-18 | 2013-03-26 | Luc Montagnier | System and method for the analysis of DNA sequences in biological fluids |
| US20130302364A1 (en) * | 2010-11-10 | 2013-11-14 | Laboratorios Del Dr. Esteve, S.A. | Highly immunogenic hiv p24 sequences |
| EP2864787B1 (en) * | 2012-06-22 | 2017-11-01 | Bio-Rad Laboratories, Inc. | Human factor xiii as a normalization control for immunoassays |
| US9823249B2 (en) * | 2012-12-12 | 2017-11-21 | Brigham And Women's Hospital, Inc. | System and method for detecting pathogens |
| KR102056520B1 (ko) | 2017-03-24 | 2019-12-18 | (주)셀아이콘랩 | 인간 섬유아세포에서 콜라겐 합성 촉진 및 콜라겐 분해 효소 활성화 억제를 유도하는 펩타이드를 함유한 화장품 조성물 및 제조방법 |
| CN108997482B (zh) | 2018-08-09 | 2025-09-09 | 东莞市朋志生物科技有限公司 | 用于检测hiv-1的合成肽 |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5030714A (en) | 1986-06-23 | 1991-07-09 | Institut Pasteur | Variant of LAV viruses |
| JPH0762031B2 (ja) * | 1986-12-30 | 1995-07-05 | アメリカ合衆国 | エイズウイルスおよびエイズウイルスのタンパク質に対する細胞性免疫を誘導する合成ペプチド |
| NO881151L (no) * | 1987-03-27 | 1988-09-28 | Syntello Ab | Syntetisk hiv-1-antigen. |
| CA1339363C (en) * | 1987-05-01 | 1997-08-26 | Alan Ray Flesher | Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use |
| JPH0215098A (ja) * | 1987-05-18 | 1990-01-18 | Virovahl Sa | Ｈｉｖ−１感染検出用合成ペプチド杭原、その組成物およびその使用方法 |
| US5019387A (en) * | 1987-09-08 | 1991-05-28 | Duke University | Production of antibodies to HIV |
| IL88963A (en) * | 1988-01-27 | 1996-05-14 | Iaf Biochem Int | Circular synthetic peptides and their mixtures for the detection of VIH antibodies and for the formation of vaccines |
| EP0330359A3 (en) | 1988-02-25 | 1991-06-05 | Bio-Rad Laboratories, Inc. | Composition useful in the diagnosis and treating of hiv-1 infection |
| ES2072853T3 (es) | 1988-06-09 | 1995-08-01 | Innogenetics Nv | Retrovirus hiv-3 y su utilizacion. |
| ATE135113T1 (de) * | 1988-12-20 | 1996-03-15 | Clarity Technologies Inc | Synthetische hiv ähnliche peptide, deren zusammensetzungen und verwendungen |
| GB8910145D0 (en) * | 1989-05-03 | 1989-06-21 | Connaught Lab | Synthetic peptides for an hiv-1 vaccine |
| ZA903492B (en) * | 1989-05-15 | 1991-02-27 | Akzo Nv | T-lymphotropic retrovirus monoclonal antibodies |
| FR2647810B1 (fr) * | 1989-06-02 | 1994-07-22 | Pasteur Institut | Amorces oligonucleotidiques pour l'amplification du genome des retrovirus du type hiv-2 et siv, et leurs applications au diagnostic in vitro des infections dues a ces virus |
| DE3934366A1 (de) * | 1989-10-14 | 1991-04-18 | Chemotherapeutisches Forschungsinstitut Georg Speyer Haus | Vakzine zum schutz vor hiv-virusinfektionen, verfahren zu ihrer herstellung und ihre verwendung als diagnostikum und immuntherapeutikum |
| US5480967A (en) * | 1990-01-05 | 1996-01-02 | United Biomedical, Inc. | HIV-1 core protein fragments |
| IL99077A0 (en) * | 1990-08-13 | 1992-07-15 | Merck & Co Inc | New embodiments of the hiv principal neutralizing determinant and pharmaceutical compositions containing them |
| JPH06500923A (ja) * | 1990-09-21 | 1994-01-27 | カイロン コーポレイション | パッケージング細胞 |
| US7115554B1 (en) | 1993-05-06 | 2006-10-03 | Acorda Therapeutics, Inc. | Methods of increasing myotube formation or survival or muscle cell mitogenesis differentiation or survival using neuregulin GGF III |
| JP2541030B2 (ja) * | 1991-04-22 | 1996-10-09 | 富士ゼロックス株式会社 | ヒドロキシインジウムフタロシアニンの新規結晶及びそれを用いた電子写真感光体 |
| JP3443809B2 (ja) * | 1992-03-06 | 2003-09-08 | エヌ・ブイ・インノジェネティクス・ソシエテ・アノニム | 免疫学的に重要なエピトープに相当するペプチドの決定方法、及び免疫学的に重要なエピトープに相当するビオチニル化ペプチド又は抗体の決定のための方法におけるその利用、その調製方法及びそれを含む組成物 |
| ES2053413T3 (es) * | 1992-05-14 | 1997-11-16 | Polymun Scient Immunbio Forsch | Peptidos que inducen anticuerpos que neutralizan aislados de vih-1 geneticamente divergentes. |
| JP3207535B2 (ja) | 1992-08-07 | 2001-09-10 | 森永乳業株式会社 | 抗酸化剤 |
| ES2126620T5 (es) | 1992-10-06 | 2010-05-21 | Siemens Healthcare Diagnostics Products Gmbh | Retrovirus del grupo de los vih y su utilizacion. |
| WO1994028871A1 (en) | 1993-06-07 | 1994-12-22 | Endocon, Inc. | Implant stimulated cellular immunity |
| KR960703136A (ko) | 1993-06-09 | 1996-06-19 | 미첼 클레인 | 탠덤 합성 hiv-1 펩티드들 |
| FR2707091B1 (fr) * | 1993-06-30 | 1997-04-04 | Cohen Haguenauer Odile | Vecteur rétroviral pour le transfert et l'expression de gènes dans des cellules eucaryotes. |
| PT787191E (pt) | 1994-10-20 | 2007-12-06 | Pasteur Institut | Sequências nucleotídicas de antigénios retroviraisde vih do tipo (ou sub-tipo) o |
| DE19622088A1 (de) | 1996-05-31 | 1997-12-04 | Boehringer Mannheim Gmbh | Anti-HIV-Antikörper als Kontrollproben |
-
1995
- 1995-10-20 PT PT95935996T patent/PT787191E/pt unknown
- 1995-10-20 DK DK95935996.9T patent/DK0787191T4/da active
- 1995-10-20 EP EP95935996A patent/EP0787191B2/fr not_active Expired - Lifetime
- 1995-10-20 CA CA2202408A patent/CA2202408C/fr not_active Expired - Lifetime
- 1995-10-20 ES ES95935996T patent/ES2293643T5/es not_active Expired - Lifetime
- 1995-10-20 WO PCT/FR1995/001391 patent/WO1996012809A2/fr not_active Ceased
- 1995-10-20 CN CN2010102008955A patent/CN102134609A/zh active Pending
- 1995-10-20 EP EP07003648A patent/EP1849869A3/fr not_active Withdrawn
- 1995-10-20 CA CA2652992A patent/CA2652992C/fr not_active Expired - Lifetime
- 1995-10-20 JP JP51369296A patent/JP4278174B2/ja not_active Expired - Lifetime
- 1995-10-20 US US08/817,441 patent/US6399294B1/en not_active Expired - Lifetime
- 1995-10-20 AU AU38089/95A patent/AU715731B2/en not_active Expired
- 1995-10-20 CN CNB951963678A patent/CN1147586C/zh not_active Expired - Lifetime
- 1995-10-20 AT AT95935996T patent/ATE374253T1/de active
- 1995-10-20 DE DE69535601T patent/DE69535601T3/de not_active Expired - Lifetime
- 1995-10-20 CN CN2004100078820A patent/CN1651457B/zh not_active Expired - Lifetime
-
2001
- 2001-12-27 US US10/026,741 patent/US7157225B2/en not_active Expired - Fee Related
-
2005
- 2005-05-24 AU AU2005202281A patent/AU2005202281B2/en not_active Expired
-
2006
- 2006-11-02 US US11/591,678 patent/US8236324B2/en not_active Expired - Fee Related
-
2008
- 2008-05-07 JP JP2008121431A patent/JP4589420B2/ja not_active Expired - Lifetime
-
2009
- 2009-06-09 JP JP2009138688A patent/JP2009240315A/ja not_active Withdrawn
- 2009-09-10 AU AU2009213045A patent/AU2009213045B2/en not_active Expired
-
2010
- 2010-03-04 JP JP2010048112A patent/JP2010172335A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009240315A5 (enExample) | ||
| Claireaux et al. | A public antibody class recognizes an S2 epitope exposed on open conformations of SARS-CoV-2 spike | |
| Pancera et al. | Structure and immune recognition of trimeric pre-fusion HIV-1 Env | |
| CN102264896B (zh) | 抗人流感病毒人型抗体 | |
| CN103476929B (zh) | 抗流感病毒中和抗体及其筛选方法 | |
| EP2975053B9 (en) | Broadly neutralizing antibody and uses thereof | |
| CN103163299A (zh) | 禽白血病双抗体夹心elisa抗原检测试剂盒 | |
| Wang et al. | HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodies | |
| CN106434568B (zh) | 一种抗猪流行性腹泻病毒s蛋白杂交瘤细胞株及其应用 | |
| CN113577257B (zh) | 细粒棘球绦虫EgTeg和EgFABP1多表位疫苗及应用 | |
| WO2013095091A2 (en) | Rsv g protein specific antibodies | |
| CN102775469B (zh) | 甲型流感病毒核衣壳蛋白的抗原表位及其用途 | |
| CN104744572B (zh) | 禽和猪戊型肝炎病毒共有抗原、单克隆抗体和制备方法及应用 | |
| RU2013143295A (ru) | Способ быстрого отбора вариантов gp-120 вич | |
| Zhou et al. | SARS-CoV-2 hijacks neutralizing dimeric IgA for enhanced nasal infection and injury | |
| CN116217716A (zh) | 一种识别柯萨奇病毒a2、a4和a5的单克隆抗体及其应用 | |
| CN103030693B (zh) | 高致病性禽流感的中和分子及其制备方法 | |
| Peng et al. | Identification of one peptide which inhibited infectivity of avian infectious bronchitis virus in vitro | |
| CN115087667B (zh) | 特异性结合SARS-CoV-2的抗原结合蛋白 | |
| CN104193827B (zh) | 一种丙型肝炎病毒第一高变区融合抗原及其应用 | |
| CN104151399A (zh) | 博卡病毒(HBoV)共有的特异性表位、其应用及其抗体 | |
| Wang et al. | Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines | |
| CN107541522A (zh) | 抗埃博拉病毒gp蛋白的单克隆抗体及其应用 | |
| Guerra et al. | Broadening sarbecovirus neutralization with bispecific antibodies combining distinct conserved targets on the receptor binding domain | |
| Luo et al. | Humanized antibody potently neutralizes all SARS-CoV-2 variants by a novel mechanism |